XMV:CA:TSX-iShares MSCI Canada Minimum Volatility (CAD)

ETF | Canadian Equity |

Last Closing

CAD 45.54

Change

-0.06 (-0.13)%

Market Cap

CAD 0.23B

Volume

9.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Canadian Equity

Symbol Name Price(Change) Market Cap
XIU:CA iShares S&P/TSX 60

-0.01 (-0.03%)

CAD 13.94B
XIC:CA iShares Core S&P/TSX Capped Co..

-0.03 (-0.08%)

CAD 13.18B
ZCN:CA BMO S&P/TSX Capped Composite

-0.03 (-0.08%)

CAD 8.49B
VCN:CA Vanguard FTSE Canada All Cap

N/A

CAD 7.69B
ZLB:CA BMO Low Volatility Canadian Eq..

-0.26 (-0.54%)

CAD 3.97B
HXT:CA Global X S&P/TSX 60™ Index ..

-0.07 (-0.11%)

CAD 3.96B
VCE:CA Vanguard FTSE Canada

-0.01 (-0.02%)

CAD 1.96B
QCN:CA Mackenzie Canadian Equity Inde..

+0.04 (+0.03%)

CAD 1.56B
WXM:CA First Asset Morningstar Canada..

-0.04 (-0.13%)

CAD 0.56B
XESG:CA iShares ESG Aware MSCI Canada ..

N/A

CAD 0.43B

ETFs Containing XMV:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Canadian Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.23% 79% B- 68% D+
Dividend Return 2.18% 64% D 50% F
Total Return 18.41% 83% B 69% C-
Trailing 12 Months  
Capital Gain 26.82% 76% C+ 70% C-
Dividend Return 2.97% 60% D- 50% F
Total Return 29.79% 69% C- 70% C-
Trailing 5 Years  
Capital Gain 43.70% 21% F 66% D+
Dividend Return 13.97% 71% C- 57% F
Total Return 57.68% 31% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.27% N/A N/A 65% D
Dividend Return 10.83% N/A N/A 68% D+
Total Return 2.56% N/A N/A 65% D
Risk Return Profile  
Volatility (Standard Deviation) 10.93% N/A N/A 81% B-
Risk Adjusted Return 99.08% N/A N/A 96% N/A
Market Capitalization 0.23B 57% F 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.